ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 146 filers reported holding ALLAKOS INC in Q4 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $100,821 | -59.8% | 11,974 | -72.8% | 0.00% | -100.0% |
| Q1 2022 | $251,000 | -44.6% | 44,061 | -4.8% | 0.00% | 0.0% |
| Q4 2021 | $453,000 | -36.1% | 46,299 | +591.0% | 0.00% | -66.7% |
| Q3 2021 | $709,000 | +3.8% | 6,700 | -16.2% | 0.00% | +50.0% |
| Q2 2021 | $683,000 | -41.2% | 8,000 | -3.6% | 0.00% | -60.0% |
| Q4 2020 | $1,162,000 | +18.9% | 8,300 | -39.0% | 0.01% | -28.6% |
| Q2 2020 | $977,000 | – | 13,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 4,887,932 | $561,037,000 | 86.41% |
| Fairmount Funds Management LLC | 147,662 | $16,949,000 | 7.14% |
| NEA Management Company, LLC | 2,164,704 | $248,465,000 | 5.58% |
| Redmile Group, LLC | 2,419,418 | $277,701,000 | 3.91% |
| Samsara BioCapital, LLC | 146,259 | $16,788,000 | 3.10% |
| Samsara BioCapital, LLC | 83,000 | $9,527,000 | 1.76% |
| Rock Springs Capital Management LP | 305,706 | $35,089,000 | 0.77% |
| Tekla Capital Management LLC | 163,645 | $18,783,000 | 0.65% |
| Legal Advantage Investments, Inc. | 7,000 | $803,000 | 0.60% |
| Eventide Asset Management | 317,000 | $36,385,000 | 0.54% |